bf/NASDAQ:FDMT_icon.jpeg

COM:4DMOLECULARTHERAPEUTICS

4D Molecular Therapeutics Inc

  • Stock

USD

Last Close

7.99

22/11 21:00

Market Cap

1.20B

Beta: -

Volume Today

2.60K

Avg: -

Company Overview

Metric
Company Name4BridgeBio Pharma
SymbolFDMT
MSH IDCOM:4DMOLECULARTHERAPEUTICSCOM:BRIDGEBIOPHARMA
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryBiotechnologyBiotechnology
CountryUSUS
StagePost-IPO Equity
Employee Count171
Website4dmoleculartherapeutics.combridgebiopharma.com
LinkedIn4d-molecular-therapeutics-llc
Founders

Market Metrics

Metric
Market Cap1.20B
Enterprise Value
Monthly Web Traffic10.96K23.81K
Web Traffic Growth2.150.19
Valuation
Raised Capital300M250M

Financial Performance

Metric
Revenue20.72M
Revenue (LTM)
Revenue (NTM)
Gross Profit14.97M
EBITDA-107.12M
Operating Income-112.87M
Net Income-100.84M
EPS-2.58
Diluted EPS-2.58
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.64
Operating Profit Margin-5.45
EBITDA Margin-5.17
Net Profit Margin-4.80
Return on Equity5.09
Return on Assets-0.17
Return on Capital Employed-0.20

Valuation Multiples

Metric
P/E Ratio-14.82
P/B Ratio4.24
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio80.26
EV Multiple-4.91

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle-141.50
Asset Turnover0.06

Cash Flow Metrics

Metric
Operating Cash Flow-75.79M
Free Cash Flow-78.56M
Cash Flow to Debt-4.02
Operating Cash Flow/Sales-2.72
Free Cash Flow Yield-0.05

Balance Sheet Metrics

Metric
Cash & Equivalents249.11M
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization0.05
Debt to Assets0.04
Current Ratio18.07
Quick Ratio32.65

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.82
R&D to Revenue4.21
SG&A to Revenue1.56